Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

3(27%)

Results Posted

40%(2 trials)

Terminated

1(9%)

Phase Distribution

Ph phase_2

27%

Ph phase_4

Ph phase_1

36%

Ph phase_3

Ph early_phase_1

18%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Early Phase 1First-in-human

2(18.2%)

Phase 1Safety & dosage

4(36.4%)

Phase 2Efficacy & side effects

3(27.3%)

Phase 3Large-scale testing

1(9.1%)

Phase 4Post-market surveillance

1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(5)

Terminated(3)

Detailed Status

Completed5

Withdrawn2

Active, not recruiting2

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (18.2%)

Phase 14 (36.4%)

Phase 23 (27.3%)

Phase 31 (9.1%)

Phase 41 (9.1%)

Trials by Status

terminated19%

withdrawn218%

completed545%

recruiting19%

active_not_recruiting218%

Recent Activity

3 active trials

Showing 5 of 11

completedphase_1

A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients

NCT03541486

View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials

NCT01852890Phase 1

Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I

Completed

NCT03602235Phase 1

High Dose Ascorbic Acid for Plasma Cell Disorders

Completed

NCT06018883Phase 3

Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer

Active Not Recruiting

NCT04634227Early Phase 1

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Active Not Recruiting

NCT03541486Phase 2

A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients

Withdrawn

NCT01752491Phase 1

A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme

Completed

NCT03508726Phase 1

High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas

Completed

NCT06018896Phase 2

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Recruiting

NCT04877587Early Phase 1

Gemcitabine With Ascorbate Including Adolescents

Withdrawn

NCT03468075Phase 2

Gemcitabine Plus Ascorbate for Sarcoma in Adults

Terminated

NCT00140166Phase 4

Treatment of Acute Schizophrenia With Vitamin Therapy

Completed

All 11 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 11